A. Yosry

1.3k total citations
19 papers, 268 citations indexed

About

A. Yosry is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, A. Yosry has authored 19 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 12 papers in Epidemiology and 3 papers in Rheumatology. Recurrent topics in A. Yosry's work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Liver Disease and Transplantation (5 papers). A. Yosry is often cited by papers focused on Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Liver Disease and Transplantation (5 papers). A. Yosry collaborates with scholars based in Egypt, South Korea and Philippines. A. Yosry's co-authors include Gamal Esmat, Wahid Doss, Mohamed Hassany, Wafaa Elakel, Imam Waked, Manal H. El‐Sayed, Magdy El‐Serafy, Mohamed El‐Kassas, Marwa Khairy and Mohamed Shaker and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Journal of Hepatology.

In The Last Decade

A. Yosry

18 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Yosry Egypt 7 245 220 20 19 15 19 268
Seth N. Sclair United States 9 205 0.8× 189 0.9× 50 2.5× 57 3.0× 9 0.6× 23 265
Milotka Fabri Serbia 6 163 0.7× 165 0.8× 48 2.4× 9 0.5× 5 0.3× 27 223
Lorena De Moliner Italy 10 374 1.5× 366 1.7× 17 0.8× 10 0.5× 29 1.9× 13 429
Nicole M. F. van Gerven Netherlands 4 220 0.9× 178 0.8× 7 0.3× 62 3.3× 36 2.4× 4 235
Claire Wartelle France 5 167 0.7× 147 0.7× 16 0.8× 38 2.0× 9 0.6× 8 194
S. Bartolacci Italy 5 405 1.7× 398 1.8× 22 1.1× 9 0.5× 14 0.9× 8 423
Manuela Curescu Romania 9 259 1.1× 263 1.2× 29 1.4× 9 0.5× 14 0.9× 24 294
H. Fontaine France 7 275 1.1× 265 1.2× 35 1.8× 5 0.3× 17 1.1× 22 286
Simon Pape Netherlands 8 211 0.9× 190 0.9× 11 0.6× 54 2.8× 28 1.9× 12 243
Alison Uriel United Kingdom 7 172 0.7× 150 0.7× 46 2.3× 5 0.3× 10 0.7× 10 211

Countries citing papers authored by A. Yosry

Since Specialization
Citations

This map shows the geographic impact of A. Yosry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Yosry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Yosry more than expected).

Fields of papers citing papers by A. Yosry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Yosry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Yosry. The network helps show where A. Yosry may publish in the future.

Co-authorship network of co-authors of A. Yosry

This figure shows the co-authorship network connecting the top 25 collaborators of A. Yosry. A scholar is included among the top collaborators of A. Yosry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Yosry. A. Yosry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Farid, Alyaa, et al.. (2019). A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis. British Journal of Biomedical Science. 76(3). 105–110. 1 indexed citations
4.
Attia, Dina, Wafaa Elakel, A. Yosry, et al.. (2018). The adverse effects of interferon‐free regimens in 149 816 chronic hepatitis C treated Egyptian patients. Alimentary Pharmacology & Therapeutics. 47(9). 1296–1305. 14 indexed citations
5.
Alem, Shereen Abdel, et al.. (2017). Improvement of glycemic state among responders to sofosbuvir – based DAAs. Journal of Hepatology. 66(1). S309–S310. 1 indexed citations
6.
Yosry, A., et al.. (2017). Sofosbuvir based therapy for recurrent hepatitis C post liver transplantation: an Egyptian experience. Journal of Hepatology. 66(1). S437–S437. 1 indexed citations
7.
Saad, Yasmin, et al.. (2017). Prevalence of thyroid dysfunction among 21672 Egyptian patients with chronic HCV genotype IV. Journal of Hepatology. 66(1). S703–S704. 1 indexed citations
8.
Elakel, Wafaa, Manal H. El‐Sayed, Mohamed El‐Kassas, et al.. (2017). National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care. Journal of Viral Hepatitis. 24(4). 262–267. 140 indexed citations
9.
Fouad, Rabab, Wafaa Elakel, Maissa El Raziky, et al.. (2017). Sofosbuvir‐based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt. Alimentary Pharmacology & Therapeutics. 45(5). 681–687. 60 indexed citations
10.
Omran, Dalia, et al.. (2017). Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. British Journal of Biomedical Science. 75(1). 19–23. 7 indexed citations
11.
12.
Shiha, Gamal, Gamal Esmat, A. Yosry, et al.. (2016). Ombitasvir/Paritaprevir/Ritonavir with Ribavirin Achieves High Sustained Virologic Response (SVR) Rates in Egyptian Adults with Chronic HCV Genotype 4 Infection (Agate-II). Journal of Hepatology. 64(2). S772–S772. 4 indexed citations
13.
El‐Kassas, Mohamed, Maissa El Raziky, Tamer Elbaz, et al.. (2016). Sofosbuvir plus Simeprevir in Treatment-Naive and Treatment-Experienced Egyptian Patients with Hepatitis C Virus Infection: A Real Life Experience. Journal of Hepatology. 64(2). S769–S770. 1 indexed citations
14.
Doss, Wahid, Gamal Esmat, Wafaa Elakel, et al.. (2016). Real-Life Results of Sofosbuvir Based Therapy for Egyptian Patients with Hepatitis C and Advanced Fibrosis-Cirrhosis. Journal of Hepatology. 64(2). S772–S772. 6 indexed citations
15.
16.
Doss, Wahid, et al.. (2014). P1164 THE DISEASE BURDEN OF CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN EGYPT: FUTURE IMPACT OF VARYING TREATMENT STRATEGIES. Journal of Hepatology. 60(1). S472–S472. 1 indexed citations
17.
Yosry, A., Gamal Esmat, Magdy El‐Serafy, et al.. (2008). Outcome of Living Donor Liver Transplantation for Egyptian Patients With Hepatitis C (Genotype 4)-Related Cirrhosis. Transplantation Proceedings. 40(5). 1481–1484. 9 indexed citations
18.
Esmat, Gamal, A. Yosry, Mostafa El-Serafi, et al.. (2005). Donor Outcomes in Right Lobe Adult Living Donor Liver Transplantation: Single-Center Experience in Egypt. Transplantation Proceedings. 37(7). 3147–3150. 14 indexed citations
19.
Hamouda, Wael, et al.. (1995). Neoadjuvant chemotherapy of locally advanced non-small cell lung cancer. Lung Cancer. 13(2). 228–228. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seth N. Sclair Breakdown of academic impact, for papers by Milotka Fabri Breakdown of academic impact, for papers by Lorena De Moliner Breakdown of academic impact, for papers by Nicole M. F. van Gerven Breakdown of academic impact, for papers by Claire Wartelle Breakdown of academic impact, for papers by S. Bartolacci Breakdown of academic impact, for papers by Manuela Curescu Breakdown of academic impact, for papers by H. Fontaine Breakdown of academic impact, for papers by Simon Pape Breakdown of academic impact, for papers by Alison Uriel
Rankless by CCL
2026